These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells. Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802 [TBL] [Abstract][Full Text] [Related]
4. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750 [TBL] [Abstract][Full Text] [Related]
5. Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity. Fultang N; Illendula A; Chen B; Wu C; Jonnalagadda S; Baird N; Klase Z; Peethambaran B PLoS One; 2019; 14(5):e0217789. PubMed ID: 31150511 [TBL] [Abstract][Full Text] [Related]
6. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells. Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308 [TBL] [Abstract][Full Text] [Related]
7. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis. Hu S; Duan YX; Zhou Q; Wang Y; Lu Q IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway. Sun W; Zu S; Shao G; Wang W; Gong F J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171 [TBL] [Abstract][Full Text] [Related]
9. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma. Liu Y; Yang H; Chen T; Luo Y; Xu Z; Li Y; Yang J PLoS One; 2015; 10(5):e0127092. PubMed ID: 25978653 [TBL] [Abstract][Full Text] [Related]
10. Penta-O-galloyl-β-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells. Lin VC; Kuo PT; Lin YC; Chen Y; Hseu YC; Yang HL; Kao JY; Ho CT; Way TD J Agric Food Chem; 2014 Sep; 62(36):8990-6. PubMed ID: 25123845 [TBL] [Abstract][Full Text] [Related]
11. Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1. Hu H; Zhang J; Lee HJ; Kim SH; Lü J Carcinogenesis; 2009 May; 30(5):818-23. PubMed ID: 19269999 [TBL] [Abstract][Full Text] [Related]
12. Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Chang YM; Bai L; Liu S; Yang JC; Kung HJ; Evans CP Oncogene; 2008 Oct; 27(49):6365-75. PubMed ID: 18679417 [TBL] [Abstract][Full Text] [Related]
13. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways. Lim W; Park S; Bazer FW; Song G J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834 [TBL] [Abstract][Full Text] [Related]
14. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling. Park N; Baek HS; Chun YJ PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009 [TBL] [Abstract][Full Text] [Related]
15. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells. Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471 [TBL] [Abstract][Full Text] [Related]
16. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties. Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201 [TBL] [Abstract][Full Text] [Related]
17. Insulin receptor signaling activated by penta-O-galloyl-α-D: -glucopyranose induces p53 and apoptosis in cancer cells. Cao Y; Evans SC; Soans E; Malki A; Liu Y; Liu Y; Chen X Apoptosis; 2011 Sep; 16(9):902-13. PubMed ID: 21671008 [TBL] [Abstract][Full Text] [Related]
18. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth. Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980 [TBL] [Abstract][Full Text] [Related]
19. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species-mediated activation of JNK and down-regulation of DAXX are critically involved in penta-O-galloyl-beta-d-glucose-induced apoptosis in chronic myeloid leukemia K562 cells. Kwon TR; Jeong SJ; Lee HJ; Lee HJ; Sohn EJ; Jung JH; Kim JH; Jung DB; Lu J; Kim SH Biochem Biophys Res Commun; 2012 Aug; 424(3):530-7. PubMed ID: 22771329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]